Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) gapped up prior to trading on Tuesday. The stock had previously closed at $64.76, but opened at $67.12. Tempus AI shares last traded at $64.2550, with a volume of 931,207 shares changing hands.
Analyst Ratings Changes
TEM has been the subject of several research analyst reports. JPMorgan Chase & Co. lifted their price objective on Tempus AI from $45.00 to $70.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 14th. Roth Capital started coverage on Tempus AI in a research report on Tuesday, September 8th. They set a “neutral” rating and a $67.00 price target for the company. Canaccord Genuity Group raised their target price on Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, October 12th. BTIG Research lifted their price objective on shares of Tempus AI from $80.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 3rd. Finally, Jefferies Financial Group upgraded shares of Tempus AI from an “underperform” rating to a “hold” rating and raised their price objective for the company from $35.00 to $70.00 in a research report on Tuesday, November 3rd. Eleven investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $79.37.
View Our Latest Analysis on Tempus AI
Tempus AI Stock Performance
The company has a current ratio of 2.61, a quick ratio of 2.48 and a debt-to-equity ratio of 2.70. The business’s fifty day simple moving average is $72.84 and its 200-day simple moving average is $57.54. The firm has a market cap of $11.37 billion, a P/E ratio of -58.53 and a beta of 3.61.
Tempus AI (NASDAQ:TEM – Get Free Report) last posted its earnings results on Monday, November 2nd. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.09) by $0.16. The firm had revenue of $411.54 million during the quarter, compared to analysts’ expectations of $409.39 million. Tempus AI had a negative net margin of 12.54% and a negative return on equity of 47.00%. The company’s quarterly revenue was up 23.1% compared to the same quarter last year. During the same period last year, the company posted ($0.46) EPS. As a group, sell-side analysts expect that Tempus AI, Inc. will post -1.20 earnings per share for the current year.
Insider Activity
In other news, CEO Eric P. Lefkofsky sold 250,000 shares of Tempus AI stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $77.47, for a total value of $19,367,500.00. Following the completion of the sale, the chief executive officer directly owned 100,000 shares in the company, valued at $7,747,000. The trade was a 71.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Ryan M. Bartolucci sold 7,062 shares of the stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $75.00, for a total transaction of $529,650.00. Following the completion of the transaction, the chief accounting officer owned 60,804 shares in the company, valued at $4,560,300. This trade represents a 10.41% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 1,012,689 shares of company stock valued at $74,249,653. 24.26% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Tempus AI
Several large investors have recently added to or reduced their stakes in the company. V Square Quantitative Management LLC purchased a new stake in shares of Tempus AI during the third quarter worth about $27,000. Edmond DE Rothschild Holding S.A. purchased a new stake in Tempus AI in the third quarter worth $33,000. EMC Capital Management purchased a new position in shares of Tempus AI during the second quarter worth approximately $29,000. Ulland Investment Advisors LLC purchased a new stake in shares of Tempus AI in the 3rd quarter worth $41,000. Finally, Heritage Family Offices LLP purchased a new position in shares of Tempus AI in the 3rd quarter valued at $45,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.
About Tempus AI
Tempus AI is a technology company focused on applying data and artificial intelligence to healthcare, with an emphasis on precision medicine. Its platform combines clinical and molecular data to help physicians make more informed treatment decisions and support life-sciences research. The company provides genomic sequencing and other diagnostic testing, software tools for analyzing patient data, and services that help identify clinical trial opportunities. Its work spans oncology and other areas of medicine, and it collaborates with healthcare providers and pharmaceutical and biotechnology companies.
Recommended Stories
- Five stocks we like better than Tempus AI
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
- Tyson Foods’ Earnings Beat Hides a Warning for Consumer Staples Dividend Investors
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.
